Listen

Description

In this episode, Therese Markow and Dr. Joshua Woolley discuss his transition from neurology to psychiatry and his current focus on psychedelic drug therapies. He explains the mechanisms and effects of psychedelics like psilocybin and LSD, highlighting their potential to treat depression and other mental health conditions. Dr. Woolley describes controlled clinical trials at the University of California, San Francisco, where patients undergo psychedelic experiences with therapeutic support. He notes the challenges and benefits of these treatments, including long-term positive effects in alleviating depression.  He also addresses the regulatory hurdles and the potential for future FDA approval of psychedelic therapies.

 

 Key Takeaways:

 

"Almost every psychiatric illness can be thought of as an inability to change something about emotions, thoughts, or behavior. If psychedelics really do reopen these critical periods, or allow people a period of a window of changeability, that would be a real game changer." —  Dr. Joshua Woolley

 

 

Connect with Dr. Joshua Woolley:

Professional Bio: https://profiles.ucsf.edu/joshua.woolley 

LinkedIn: https://www.linkedin.com/in/joshua-d-woolley-md-phd-076018110/ 

 

Connect with Therese:

Website: www.criticallyspeaking.net

Threads: @critically_speaking

Email: theresemarkow@criticallyspeaking.net

 

  

Audio production by Turnkey Podcast Productions. You're the expert. Your podcast will prove it.